The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Nov. 05, 2018
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Erika M. V. Araujo, Woodbridge, CT (US);

Yan Chen, Yardley, PA (US);

Bireshwar Dasgupta, Doylestown, PA (US);

Andrew P. Degnan, Jamison, PA (US);

Matthew D. Hill, Windham, NH (US);

Godwin Kwame Kumi, Morrisville, PA (US);

Harold A. Mastalerz, Guilford, CT (US);

Mark D. Wittman, Hopkinton, MA (US);

Bradley C. Pearce, East Hampton, CT (US);

Guifen Zhang, Hopkinton, MA (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 453/02 (2006.01); C07D 491/048 (2006.01); C07D 498/10 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 453/02 (2013.01); C07D 491/048 (2013.01); C07D 498/10 (2013.01); C07D 519/00 (2013.01);
Abstract

Disclosed are compounds of Formula (I) or a salt thereof, wherein: X is CH or N; Y is CR5 or N; and R1, R2, R3, R4, and R5 are defined herein. Also disclosed are methods of using such compounds to modulate or inhibit the enzymatic activity of hematopoietic progenitor kinase 1 (HPK1), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.


Find Patent Forward Citations

Loading…